Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Clinical trial NCT03541603 · COMPLETED

Trial details

NCT number: NCT03541603
Sponsor: Tenax Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction

Start date: 2018-11-14
Primary completion: 2020-04-07
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.